NEW YORK - 
(NewMediaWire) - October 14, 2021 - Faruqi & Faruqi, LLP, a
leading national securities law firm, is investigating potential claims against
Ginkgo Bioworks Holdings, Inc. (“Ginkgo
Bioworks” or the “Company”) (NYSE: DNA).
If you suffered losses exceeding $50,000 investing in Ginkgo Bioworks stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: http://www.faruqilaw.com/DNA.
There is no cost or obligation to you.
Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Delaware, Pennsylvania, California and Georgia.
On October 6, 2021, Scorpion Capital published a report about Ginkgo alleging that it is a "colossal scam." It describes the Company's business model as a "shell game," and that the company is highly dependent on related party transaction revenues. The report also calls the company a "Frankenstein mash-up of the worst frauds of the last 20 years."
On this news, the Company’s share price fell as much as 20%, during intraday trading on October 6, 2021, thereby injuring investors.
Attorney Advertising. The law firm responsible for this
advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We welcome the opportunity to discuss your
particular case. All communications will
be treated in a confidential manner.
